A liver organoid developed by Swiss researchers holds enormous potential in the field of liver transplantation and research into liver diseases.
Biologists and bioengineers at EPFL have developed a new technique for growing miniature human livers from bipotent stem cells. Unlike current commercial substrates, the EPFL matrix is chemically defined – rather than based on animal products. The real innovation lies in the culture medium. The researchers have developed a polyethylene glycol matrix that acts as a structural framework. It is a kind of scaffold to which the researchers have added peptides (small proteins) that enable them to bind liver cells.
Their method could help pave the way for the transplantation of laboratory-grown organs. In the shorter term, it will also serve as a scientific model for testing treatments for non-alcoholic fatty liver disease – the most common liver condition in Western countries. It is now up to clinical researchers to take the reins.
Reference: https://actu.epfl.ch/news/transplantable-lab-grown-organs-move-a-step-closer
Nat Commun 11, 3416 (2020).
https://doi.org/10.1038/s41467-020-17161-0